메뉴 건너뛰기
JAMA Dermatology
Volumn 150, Issue 3, 2014, Pages 332-334
Fluorouracil and other predictors of morpheaform basal cell carcinoma among high-risk patients: The veterans affairs topical tretinoin chemoprevention trial
Author keywords

[No Author keywords available]
Indexed keywords

FLUOROURACIL;
EID: 84896075674     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.5619     Document Type: Article
Times cited : (7)
References (7)
  • 1
    • 84867848114 scopus 로고    scopus 로고
    • Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial
    • VATTC Trial Group
    • Dyer RK, Weinstock MA, Cohen TS, Rizzo AE, Bingham SF; VATTC Trial Group. Predictors of basal cell carcinoma in high-risk patients in the VATTC (VA Topical Tretinoin Chemoprevention) trial. J Invest Dermatol. 2012;132(11):2544-2551.
    • (2012) J Invest Dermatol , vol.132 , Issue.11 , pp. 2544-2551
    • Dyer, R.K.1    Weinstock, M.A.2    Cohen, T.S.3    Rizzo, A.E.4    Bingham, S.F.5
  • 2
    • 73149117784 scopus 로고    scopus 로고
    • Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: A systematic review
    • Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol. 2009;145(12):1431-1438.
    • (2009) Arch Dermatol , vol.145 , Issue.12 , pp. 1431-1438
    • Love, W.E.1    Bernhard, J.D.2    Bordeaux, J.S.3
  • 3
    • 34548567532 scopus 로고    scopus 로고
    • Management of nonmelanoma skin cancer in 2007
    • DOI 10.1038/ncponc0883, PII NCPONC0883
    • Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4(8):462-469. (Pubitemid 47393802)
    • (2007) Nature Clinical Practice Oncology , vol.4 , Issue.8 , pp. 462-469
    • Neville, J.A.1    Welch, E.2    Leffell, D.J.3
  • 4
    • 84877764756 scopus 로고    scopus 로고
    • Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone
    • Blixt E, Nelsen D, Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatol Surg. 2013;39(5):719-725.
    • (2013) Dermatol Surg , vol.39 , Issue.5 , pp. 719-725
    • Blixt, E.1    Nelsen, D.2    Stratman, E.3
  • 5
    • 84867719749 scopus 로고    scopus 로고
    • Morpheaform facial basal cell carcinoma: A 16-year experience in an Asian center
    • Teo WL, Wong CH, Song C. Morpheaform facial basal cell carcinoma: a 16-year experience in an Asian center. Int J Dermatol. 2012;51(11):1396-1398.
    • (2012) Int J Dermatol , vol.51 , Issue.11 , pp. 1396-1398
    • Teo, W.L.1    Wong, C.H.2    Song, C.3
  • 6
    • 33645518075 scopus 로고    scopus 로고
    • One-fifth of basal cell carcinomas have a morphoeic or partly morphoeic histology: Implications for treatment
    • Burdon-Jones D, Thomas PW. One-fifth of basal cell carcinomas have a morphoeic or partly morphoeic histology: implications for treatment. Australas J Dermatol. 2006;47(2):102-105.
    • (2006) Australas J Dermatol , vol.47 , Issue.2 , pp. 102-105
    • Burdon-Jones, D.1    Thomas, P.W.2
  • 7
    • 34447281502 scopus 로고    scopus 로고
    • Reliability of the histopathologic diagnosis of keratinocyte carcinomas
    • DOI 10.1016/j.jaad.2007.03.021, PII S0190962207005555
    • Jagdeo J, Weinstock MA, Piepkorn M, Bingham SF; Department of Veteran Affairs Topical Tretinoin Chemoprevention Trial Group. Reliability of the histopathologic diagnosis of keratinocyte carcinomas. J Am Acad Dermatol. 2007;57(2):279-284. (Pubitemid 47048870)
    • (2007) Journal of the American Academy of Dermatology , vol.57 , Issue.2 , pp. 279-284
    • Jagdeo, J.1    Weinstock, M.A.2    Piepkorn, M.3    Bingham, S.F.4

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.